Combining clinical features and MEST-C score in IgA nephropathy may be a better determinant of kidney survival

Creative Commons License

Yeter H. H., Işık Gönül İ., Güz G. T., Helvacı Ö., Korucu B., Akçay Ö. F., ...Daha Fazla

Romanian Journal of Internal Medicine, cilt.58, sa.4, ss.209-218, 2020 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 58 Sayı: 4
  • Basım Tarihi: 2020
  • Doi Numarası: 10.2478/rjim-2020-0025
  • Dergi Adı: Romanian Journal of Internal Medicine
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, MEDLINE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.209-218
  • Anahtar Kelimeler: IgA nephropathy, glomerulonephritis, end stage kidney disease, glucocorticoid, Oxford classification, OXFORD CLASSIFICATION, COMPLEMENT C3, THERAPY, MULTICENTER, PROGRESSION, VALIDATION
  • Gazi Üniversitesi Adresli: Evet

Özet

Introduction. IgA nephropathy (IgAN) is a heterogeneous disease with highly variable clinical and histopathological features. We investigated the effects of Oxford classification and clinical features on renal survival in patients with IgAN.